Know what’s inside:

In vitro & in vivo Pharmacology

Pharmacelsus - In vitro and in vivo Pharmacology

In-depth knowledge

To gain profound and relevant preclinical data on efficacy and potency, in-depth knowledge of the corresponding disease is a key success factor.

Pharmacelsus has a proven track record on conducting In vitro and in vivo studies on potency, selectivity and efficacy in several indication areas.

Maria Li - Pharmacelsus

Your contact at Pharmacelsus

MUDr. Maria Li
Director Business Development

Mobile: +49 173 889 4288


In vitro Pharmacology Assays

5α Reductase Inhibitors

  • Human Recombinant Isoenzymes Type I and II

In vivo Pharmacology Models

Diabetes / Metabolic Syndrome Models

  • Induced Models:
    • STZ Mice/Rats
    • DIO Mice/Rat
  • Genetic Models
    • ob / ob Mice
    • db / db Mice
    • Zucker /ZDF Rat


  • In vivo Model
    • (immunodeficient mice)
  • Principle:
    • s.c. tumor xenograft model
  • General Readouts:
    • Tumor incidence, tumor size, tumor growth inhibition, terminal tumor weight, occurrence of metastases (Postmortal)

The experienced and highly committed Pharmacelsus team offers a variety of different services the following in Areas.

Pharmacelsus - in-vitro-ADME

In vitro ADME

Pharmacelsus - in-vivo-DMPK

In vivo DMPK

Pharmacelsus - In vitro & in vivo Toxicology

In vitro & in vivo Toxicology

Pharmacelsus - G(C)LP & non-GLP Bioanalytics

G(C)LP & non-GLP Bioanalytics

Pharmacelsus - Biomarker Services

Biomarker Services

Pharmacelsus - In vitro & in vivo Pharmacology

In vitro & in vivo Pharmacology

Pharmacelsus - Preclinical Services

Preclinical Services

GBA Group Pharma

GBA Group Pharma

Business Development

Contact us!

To learn more about us and what we can do for you please contact our Director Business Development.

© 2024 GBA Group

Follow Us

  • linkedIn GBA Pharma
  • xing
  • GBA youtube
  • gba Instagram
ContactData PrivacyLegal NoticeTerms & ConditionsDisclosure
Phone Phone